Fny Investment Advisers, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Fny Investment Advisers, LLC

  • $194 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Jan 22, 2019
SELL
$19.08 - $36.14 $9,540 - $18,070
-500 Closed
0 $0
Q3 2018

Oct 29, 2018
SELL
$33.57 - $42.1 $16,785 - $21,050
-500 Reduced 50.0%
500 $19,000
Q2 2018

Jul 18, 2018
BUY
$20.06 - $44.95 $20,060 - $44,950
1,000 New
1,000 $39,000

Others Institutions Holding DCPH

# of Institutions
6
Shares Held
293K
Call Options Held
500
Put Options Held
0
View Full List

About Deciphera Pharmaceuticals, Inc.

DCPH Quotes by TradingView
  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email